marketcap
Facebook
Twitter
Telegram
Fehler meldenGeschäftsbericht 2023
hinzugefügt 21.12.2024
RedHill Biopharma Ltd. Kennzahlen 2011-2024 | RDHL
Kennzahlen Jährlich RedHill Biopharma Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | -12.3 | -4.1 | -42.6 | -33.1 | -19.9 | -42.2 | -52.0 | -12.1 | -7.4 | -5.6 | - |
P/S |
- | - | 14.0 | 4.8 | 286.5 | 153.5 | 226.5 | 12278.8 | 365685.3 | 18.5 | 6560.2 | 3615.9 | - |
EPS |
- | - | -0.2 | 0.2 | -0.1 | -0.2 | -0.3 | -0.2 | -0.2 | - | - | - | - |
EV (Enterprise Value) |
15.4 M | 187 M | 1.34 B | 447 M | 1.79 B | 1.27 B | 903 M | 1.2 B | 1.08 B | 134 M | 81.1 M | 58.9 M | 1.4 M |
EBITDA per Share |
- | - | -0.17 | -1.66 | -0.15 | -0.17 | -0.29 | -0.237 | -0.198 | -1.23 | -1.72 | -1.71 | - |
EV/EBITDA |
-11.5 | -6.1 | -38.2 | -50.3 | -22.4 | -38.9 | -49.7 | -11.7 | -6.2 | -4.6 | - | ||
PEG |
- | -0.07 | -0.02 | 2.24 | 1.47 | 1.42 | 2.1 | -0.62 | -0.41 | -0.49 | -0.15 | - | |
P/B |
- | - | 135.3 | 22.4 | 30.0 | 25.1 | 20.1 | 19.8 | 18.3 | 5.2 | 6.6 | 3.0 | - |
P/CF |
- | - | -18.5 | -6.4 | -44.2 | -37.2 | -20.3 | -43.7 | -56.4 | -9.8 | -9.1 | -8.4 | - |
ROE % |
- | - | - | -549.43 | -70.50 | -75.84 | -101.06 | -46.84 | -35.10 | -42.83 | -89.12 | -54.30 | - |
ROA % |
- | - | -53.95 | -42.26 | -57.09 | -62.20 | -79.42 | -39.58 | -31.56 | -37.12 | -74.11 | -51.38 | - |
ROCE % |
- | - | - | -459.35 | -68.05 | -75.59 | -114.19 | -44.36 | -35.88 | -39.24 | -90.33 | -47.53 | - |
Current Ratio |
1.1 | 0.8 | 1.1 | 1.1 | 5.3 | 5.6 | 4.7 | 12.7 | 11.0 | 15.1 | 5.2 | 17.2 | - |
DSO |
- | - | - | - | - | - | - | 357.8 | - | 55.4 | 12987.9 | 1916.2 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | 22.9 | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | 55.4 | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | 32.4 | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich RedHill Biopharma Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | - | - | - | 0.06 | - | - | - | 0.04 | - | - | - | 0.04 | - | - | - | 0.05 | - | - | - | 0.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | -0.05 | - | - | - | -0.03 | - | - | - | -0.04 | - | - | - | -0.04 | - | - | - | -0.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
- | - | -98.44 | -196.89 | -196.89 | -98.44 | -144.84 | -92.79 | -92.79 | -46.40 | -80.59 | -68.38 | -68.38 | -34.19 | -77.11 | -85.83 | -85.83 | -42.92 | -65.50 | -45.17 | -45.17 | -22.59 | -22.59 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
- | - | -14.30 | -28.60 | -28.60 | -14.30 | -23.94 | -19.29 | -19.29 | -9.65 | -31.60 | -43.90 | -43.90 | -21.95 | -51.33 | -58.75 | -58.75 | -29.38 | -29.38 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | -19.99 | -39.98 | -39.98 | -19.99 | -29.57 | -19.16 | -19.16 | -9.58 | -44.31 | -69.47 | -69.47 | -34.73 | -71.63 | -73.78 | -73.78 | -36.89 | -64.63 | -55.48 | -55.48 | -27.74 | -27.74 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | 1.1 | - | 1.2 | - | 1.1 | - | 1.3 | - | 5.3 | - | 2.8 | - | 5.6 | - | 3.2 | - | 4.7 | - | - | - | 6.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung